Back to Agenda
LS07: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model? DCT & Remote Utilization (Part 2)
Session Chair(s)
Hiroshi Matsuzawa, MSc
Clinical Development
Astellas Pharma Inc., Japan
Toshiharu Sano, RPh
Associate Vice President
MSD, Japan
Have an account?